Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Details

Connection

Robert MacLaren to Critical Illness

This is a "connection" page, showing publications Robert MacLaren has written about Critical Illness.

 
Connection Strength
  
 
 
7.300
  
  1. MacLaren R, Dionne JC, Granholm A, Alhazzani W, Szumita PM, Olsen K, Barletta JF, M?ller MH, Karvellas CJ, Wischmeyer P, DePriest A, Carlos V, Argetsinger D, Carothers JJ, Lee R, Napolitano L, Perri D, Naylor DF. Executive Summary-Society of Critical Care Medicine Guideline and American Society of Health-System Pharmacists for the Prevention of Stress-Related Gastrointestinal Bleeding in Critically Ill Adults. Crit Care Med. 2024 Aug 01; 52(8):1295-1299.
    View in: PubMed
    Score: 0.596
  2. MacLaren R, Dionne JC, Granholm A, Alhazzani W, Szumita PM, Olsen K, Barletta JF, M?ller MH, Karvellas CJ, Wischmeyer P, DePriest A, Carlos V, Argetsinger D, Carothers JJ, Lee R, Napolitano L, Perri D, Naylor DF. Society of Critical Care Medicine and American Society of Health-System Pharmacists Guideline for the Prevention of Stress-Related Gastrointestinal Bleeding in Critically Ill Adults. Crit Care Med. 2024 Aug 01; 52(8):e421-e430.
    View in: PubMed
    Score: 0.596
  3. MacLaren R. Considerations when administering medications enterally in the critically ill. Curr Opin Clin Nutr Metab Care. 2023 05 01; 26(3):302-306.
    View in: PubMed
    Score: 0.539
  4. MacLaren R, Brophy GM. Prevention Strategies to Improve Outcomes in Critically Ill Adults. Pharmacotherapy. 2019 03; 39(3):212-214.
    View in: PubMed
    Score: 0.412
  5. Reynolds PM, MacLaren R. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis. Pharmacotherapy. 2019 03; 39(3):408-420.
    View in: PubMed
    Score: 0.397
  6. MacLaren R. Measuring Gastric Emptying in the Critically Ill: More Than a Gut Feeling. JPEN J Parenter Enteral Nutr. 2017 09; 41(7):1087-1089.
    View in: PubMed
    Score: 0.354
  7. MacLaren R, Campbell J. The authors reply. Crit Care Med. 2014 Sep; 42(9):e637-8.
    View in: PubMed
    Score: 0.301
  8. MacLaren R, Campbell J. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*. Crit Care Med. 2014 Apr; 42(4):809-15.
    View in: PubMed
    Score: 0.292
  9. MacLaren R, Reynolds PM, Allen RR. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med. 2014 Apr; 174(4):564-74.
    View in: PubMed
    Score: 0.292
  10. MacLaren R, Krisl JC, Cochrane RE, Mueller SW. A case-based approach to the practical application of dexmedetomidine in critically ill adults. Pharmacotherapy. 2013 Feb; 33(2):165-86.
    View in: PubMed
    Score: 0.270
  11. Crona D, MacLaren R. Gastrointestinal hormone concentrations associated with gastric feeding in critically ill patients. JPEN J Parenter Enteral Nutr. 2012 Mar; 36(2):189-96.
    View in: PubMed
    Score: 0.243
  12. MacLaren R, Kiser TH, Fish DN, Wischmeyer PE. Erythromycin vs metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition in critically ill patients. JPEN J Parenter Enteral Nutr. 2008 Jul-Aug; 32(4):412-9.
    View in: PubMed
    Score: 0.196
  13. Landzinski J, Kiser TH, Fish DN, Wischmeyer PE, MacLaren R. Gastric motility function in critically ill patients tolerant vs intolerant to gastric nutrition. JPEN J Parenter Enteral Nutr. 2008 Jan-Feb; 32(1):45-50.
    View in: PubMed
    Score: 0.189
  14. Murphy DJ, Anderson W, Heavner SH, Al-Hakim T, Cruz-Cano R, Laudanski K, Kamaleswaran R, Badawi O, Engel H, Grunwell J, Herasevich V, Khanna AK, Lamb K, MacLaren R, Rincon T, Sanchez-Pinto L, Sikora AN, Stevens RD, Tanner D, Teeter W, Wong AI, Wynn JL, Zhang XT, Zimmerman JJ, Kumar V, Cobb JP, Reuter-Rice KE. Development of a Core Critical Care Data Dictionary With Common Data Elements to Characterize Critical Illness and Injuries Using a Modified Delphi Method. Crit Care Med. 2025 May 01; 53(5):e1045-e1054.
    View in: PubMed
    Score: 0.155
  15. Farrar JE, Stefanos SS, Cava L, Kiser TH, Mueller SW, Neumann R, Reynolds PM, Sherman DS, MacLaren R. Correlation Between Serum and CSF Concentrations of Midazolam and 1-Hydroxy-Midazolam in Critically Ill Neurosurgical Patients. Ann Pharmacother. 2025 Mar; 59(3):244-249.
    View in: PubMed
    Score: 0.150
  16. MacLaren R, Gasper J, Jung R, Vandivier RW. Use of exogenous erythropoietin in critically ill patients. J Clin Pharm Ther. 2004 Jun; 29(3):195-208.
    View in: PubMed
    Score: 0.148
  17. Reynolds PM, Wells L, Powell M, MacLaren R. Associated Mortality Risk of Proton Pump Inhibitor Therapy for the Prevention of Stress Ulceration in Intensive Care Unit Patients: A Systematic Review and Meta-analysis. J Clin Gastroenterol. 2023 07 01; 57(6):586-594.
    View in: PubMed
    Score: 0.139
  18. Buckley MS, Benanti GE, Gilbert B, Meckel J, Dzierba AL, MacLaren R. Correlation between heparin anti-Xa activity and thromboelastography in adult critically ill COVID-19 patients. Pharmacotherapy. 2023 08; 43(8):795-803.
    View in: PubMed
    Score: 0.138
  19. Buckley MS, Benanti GE, Meckel J, Tekle LA, Gilbert B, Puebla Neira D, McNierney DA, Korkames G, Yerondopoulos M, Park A, O'Hea JA, MacLaren R. Correlation between partial thromboplastin time and thromboelastography in adult critically ill patients requiring bivalirudin for extracorporeal membrane oxygenation. Pharmacotherapy. 2023 03; 43(3):196-204.
    View in: PubMed
    Score: 0.135
  20. Buckley MS, Mendez A, Radosevich JJ, Agarwal SK, MacLaren R. Comparison of 2 different inhaled epoprostenol dosing strategies for acute respiratory distress syndrome in critically ill adults: Weight-based vs fixed-dose administration. Am J Health Syst Pharm. 2023 02 21; 80(Suppl 1):S11-S22.
    View in: PubMed
    Score: 0.135
  21. Jung R, MacLaren R. Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients. Ann Pharmacother. 2002 Dec; 36(12):1929-37.
    View in: PubMed
    Score: 0.133
  22. Boyd C, Hassig T, MacLaren R. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU. Pharmacotherapy. 2021 10; 41(10):820-827.
    View in: PubMed
    Score: 0.122
  23. MacLaren R, Francisco J, Fetters M, Brady J, Kim C, Welker C. Oseltamivir-Associated Bradycardia in Critically Ill Patients. Ann Pharmacother. 2021 11; 55(11):1318-1325.
    View in: PubMed
    Score: 0.118
  24. MacLaren R. Intolerance to intragastric enteral nutrition in critically ill patients: complications and management. Pharmacotherapy. 2000 Dec; 20(12):1486-98.
    View in: PubMed
    Score: 0.116
  25. Lat I, Paciullo C, Daley MJ, MacLaren R, Bolesta S, McCann J, Stollings JL, Gross K, Foos SA, Roberts RJ, Acquisto NM, Taylor S, Bentley M, Jacobi J, Meyer TA. Position Paper on Critical Care Pharmacy Services (Executive Summary): 2020 Update. Crit Care Med. 2020 09; 48(9):1375-1382.
    View in: PubMed
    Score: 0.114
  26. Lat I, Paciullo C, Daley MJ, MacLaren R, Bolesta S, McCann J, Stollings JL, Gross K, Foos SA, Roberts RJ, Acquisto NM, Taylor S, Bentley M, Jacobi J, Meyer TA. Position Paper on Critical Care Pharmacy Services: 2020 Update. Crit Care Med. 2020 09; 48(9):e813-e834.
    View in: PubMed
    Score: 0.114
  27. Buckley MS, Agarwal SK, Garcia-Orr R, Saggar R, MacLaren R. Comparison of Fixed-Dose Inhaled Epoprostenol and Inhaled Nitric Oxide for Acute Respiratory Distress Syndrome in Critically Ill Adults. J Intensive Care Med. 2021 Apr; 36(4):466-476.
    View in: PubMed
    Score: 0.110
  28. Kassel LE, Van Matre ET, Foster CJ, Fish DN, Mueller SW, Sherman DS, Wempe MF, MacLaren R, Neumann RT, Kiser TH. A Randomized Pharmacokinetic and Pharmacodynamic Evaluation of Every 8-Hour and 12-Hour Dosing Strategies of Vancomycin and Cefepime in Neurocritically ill Patients. Pharmacotherapy. 2018 09; 38(9):921-934.
    View in: PubMed
    Score: 0.098
  29. Alquraini M, Alshamsi F, M?ller MH, Belley-Cote E, Almenawer S, Jaeschke R, MacLaren R, Alhazzani W. Sucralfate versus histamine 2 receptor antagonists for stress ulcer prophylaxis in adult critically ill patients: A meta-analysis and trial sequential analysis of randomized trials. J Crit Care. 2017 08; 40:21-30.
    View in: PubMed
    Score: 0.090
  30. Kwon JO, MacLaren R. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study. Pharmacotherapy. 2016 10; 36(10):1047-1054.
    View in: PubMed
    Score: 0.087
  31. Preslaski CR, Lat I, MacLaren R, Poston J. Pharmacist contributions as members of the multidisciplinary ICU team. Chest. 2013 Nov; 144(5):1687-1695.
    View in: PubMed
    Score: 0.071
  32. Owen PS, Tan EC, Kiser TH, Fish DN, MacLaren R. Reliability and accuracy of practitioner-calculated Acute Physiology and Chronic Health Evaluation II scores for determining the appropriateness of drotrecogin alfa (activated). Am J Health Syst Pharm. 2010 Jan 15; 67(2):136-43.
    View in: PubMed
    Score: 0.055
  33. Horinek EL, Kiser TH, Fish DN, MacLaren R. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions. Ann Pharmacother. 2009 Dec; 43(12):1964-71.
    View in: PubMed
    Score: 0.054
  34. Juang P, Fish DN, Jung R, MacLaren R. Enteral glutamine supplementation in critically ill patients with burn injuries: a retrospective case-control evaluation. Pharmacotherapy. 2007 Jan; 27(1):11-9.
    View in: PubMed
    Score: 0.044
  35. MacLaren R, Sullivan PW. Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients. Pharmacotherapy. 2005 Oct; 25(10):1319-28.
    View in: PubMed
    Score: 0.041
  36. MacLaren R, Jung R. Stress-dose corticosteroid therapy for sepsis and acute lung injury or acute respiratory distress syndrome in critically ill adults. Pharmacotherapy. 2002 Sep; 22(9):1140-56.
    View in: PubMed
    Score: 0.033
  37. MacLaren R, Patrick WD, Hall RI, Rocker GM, Whelan GJ, Lima JJ. Comparison of cisapride and metoclopramide for facilitating gastric emptying and improving tolerance to intragastric enteral nutrition in critically III, mechanically ventilated adults. Clin Ther. 2001 Nov; 23(11):1855-66.
    View in: PubMed
    Score: 0.031
  38. Lat I, Paciullo C, Daley MJ, MacLaren R, Bolesta S, McCann J, Stollings JL, Gross K, Foos SA, Roberts RJ, Acquisto NM, Taylor S, Bentley M, Jacobi J, Meyer TA. Position Paper on Critical Care Pharmacy Services (Executive Summary): 2020 Update. Am J Health Syst Pharm. 2020 09 18; 77(19):1619-1624.
    View in: PubMed
    Score: 0.029
  39. MacLaren R, Kuhl DA, Gervasio JM, Brown RO, Dickerson RN, Livingston TN, Swift K, Headley S, Kudsk KA, Lima JJ. Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study. Crit Care Med. 2000 Feb; 28(2):438-44.
    View in: PubMed
    Score: 0.027
  40. Van Matre ET, Reynolds PM, MacLaren R, Mueller SW, Wright GC, Moss M, Burnham EL, Ho PM, Vandivier RW, Kiser TH. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer. J Thromb Haemost. 2018 12; 16(12):2492-2500.
    View in: PubMed
    Score: 0.025
  41. Mueller SW, Baumgartner LJ, MacLaren R, Neumann R, Wiktor AJ, Kiser TH, Lindberg G, Cava L, Fish DN, Janoff EN. Divergent humoral responses to 23-valent pneumococcal polysaccharide vaccine in critically-ill burn and neurosurgical patients. PLoS One. 2018; 13(5):e0197037.
    View in: PubMed
    Score: 0.024
  42. Morris AA, Page RL, Baumgartner LJ, Mueller SW, MacLaren R, Fish DN, Kiser TH. Thiocyanate Accumulation in Critically Ill Patients Receiving Nitroprusside Infusions. J Intensive Care Med. 2017 Oct; 32(9):547-553.
    View in: PubMed
    Score: 0.021
  43. Kiser TH, Fish DN, Aquilante CL, Rower JE, Wempe MF, MacLaren R, Teitelbaum I. Evaluation of sulfobutylether-?-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy. Crit Care. 2015 Feb 03; 19:32.
    View in: PubMed
    Score: 0.019
  44. Barletta JF, Kanji S, MacLaren R, Lat I, Erstad BL. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada. J Crit Care. 2014 Dec; 29(6):955-60.
    View in: PubMed
    Score: 0.019
  45. Kiser TH, MacLaren R, Fish DN, Hassell KL, Teitelbaum I. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. Pharmacotherapy. 2010 Nov; 30(11):1117-26.
    View in: PubMed
    Score: 0.014
  46. Ogungbenro K, Vasist L, Maclaren R, Dukes G, Young M, Aarons L. A semi-mechanistic gastric emptying model for the population pharmacokinetic analysis of orally administered acetaminophen in critically ill patients. Pharm Res. 2011 Feb; 28(2):394-404.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)